FNY Investment Advisers’s Kazia Therapeutics KZIA Stock Holding History

FNY Investment Advisers’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$74K	–	958
2026 Q1	$74K	Buy	10,000 +2,500	+33%	+$17.4K	0.03%	321
2025 Q4	$51K	Buy	+7,500	New	+$63.9K	0.01%	443

Other funds holding KZIA

F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

United Bank (Virginia) Vienna, Virginia $853M AUM 34.07% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FNY Investment Advisers's KZIA Position: Q2 2026 in Review

FNY Investment Advisers sold out of Kazia Therapeutics (KZIA) in Q2 2026, closing a stake of 10,000 shares — an estimated $74K sold.

FNY Investment Advisers first reported a position in KZIA in Q4 2025 and held it in 2 quarters. The position peaked at $74K in Q1 2026. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

FNY Investment Advisers reported no remaining Kazia Therapeutics position as of Q2 2026 after selling out during the quarter.
FNY Investment Advisers sold 10,000 Kazia Therapeutics shares in Q2 2026, an estimated $74K.
FNY Investment Advisers first reported a position in Kazia Therapeutics in Q4 2025 and held it in 2 quarters.
FNY Investment Advisers's Kazia Therapeutics position peaked at $74K in Q1 2026.
6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.